CoChat

Impact of body fat distribution and sarcopenia on the overall survival in patients with spinal metastases receiving radiotherapy treatment: a prospective cohort study

Open access

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; none of the 26 sources its claims cite is checked for support yet.

Abstract

Introduction: An increasing number of patients is diagnosed with spinal metastases due to elevated cancer incidence and improved overall survival. Patients with symptomatic spinal bone metastases often receive radiotherapy with or without surgical stabilisation. Patients with a life expectancy of less than 3 months are generally deemed unfit for surgery, therefore adequate pre-treatment assessment of life expectancy is necessary. The aim of this study was to assess new factors associated with overall survival for this category of patients.Patients and methods: Patients who received radiotherapy for thoracic or lumbar spinal metastases from June 2013 to December 2016 were included in this study. The pre-treatment planning CT for radiotherapy treatment was used to assess the patient’s visceral fat area, subcutaneous fat area, total muscle area and skeletal muscle density on a single transverse slice at the L3 level. The total muscle area was used to assess sarcopenia. Furthermore, data were collected on age, sex, primary tumour, Karnofsky performance score, medical history, number of bone metastases, non-bone metastases and neurological symptoms. Univariable and multivariable cox regressions were performed to determine the association between our variables of interest and the survival at 90 and 365 days.Results: A total of 310 patients was included. The median age was 67 years. Overall survival rates for 90 and 365 days were 71% and 36% respectively. For 90- and 365-day survival, the Karnofsky performance score, muscle density and primary tumour were independently significantly associated. The visceral or subcutaneous fat area and their ratio and sarcopenia were not independently associated with overall survival.Conclusions: Of the body morphology, only muscle density was statistically significant associated with overall survival after 90 and 365 days in patients with spinal bone metastases. Body fat distribution was not significantly associated with overall survival.

Overview

CoChat Summary

TL;DR

In a prospective single-centre cohort of 310 patients receiving radiotherapy for thoracic or lumbar spinal metastases, 90- and 365-day overall survival were 71% and 36%. Muscle density, Karnofsky performance score, and primary tumour were independently associated with survival, whereas body fat distribution and sarcopenia were not independently associated.

Key findings

  • Among 310 patients (median age 67 years; median follow-up 202 days, IQR 73–576), overall survival was 71% at 90 days and 36% at 365 days; 63% were male, and the most common primary tumours were lung (28%), prostate (27%), and breast (18%).
  • In multivariable Cox regression, decreased muscle density was associated with decreased survival at 90 and 365 days, adjusted for Karnofsky performance score and primary tumour type: HR 0.62 (95% CI 0.41–0.94) and HR 0.70 (95% CI 0.53–0.92), respectively. Karnofsky performance score and primary tumour were also independently significantly associated.
  • Visceral fat area, subcutaneous fat area, VFA/SFA ratio, and sarcopenia were not independently associated with overall survival at any time point. In univariable analysis, increased age, increased VFA/SFA ratio, increased subcutaneous fat area, decreased muscle density, and sarcopenia increased the probability of death; higher Karnofsky performance score and breast or prostate cancer versus lung cancer decreased it.

Methods

  • Prospective cohort from a single centre: all patients treated with radiotherapy for thoracic or lumbar spinal bone metastases between June 2013 and December 2016 were included (n = 310); no distinction was made by radiotherapy scheme/modality or concurrent systemic therapy. Survival was defined as days from start of radiotherapy to death from all causes or end of follow-up on 31 March 2018, with vital status from a governmental database.
  • Pre-treatment radiotherapy planning CT at the L3 level was used. A single trained observer, blinded to clinical information, manually delineated the abdominal muscle wall; subcutaneous fat area, visceral fat area, total muscle area, and muscle density were measured using tissue-specific Hounsfield unit thresholds. Skeletal muscle index was total muscle area divided by height squared; sarcopenia cut-offs were <52.4 cm²/m² for males and <38.5 cm²/m² for females.
  • Univariable and multivariable Cox regressions were performed for 90- and 365-day survival. Missing data were handled with multiple imputation using Markov Chain Monte Carlo; collinearity was tested with variance inflation factor; analyses used SPSS version 22.

Limitations

  • Stated: missing data were present in 180 patients (58%), mostly Karnofsky performance score (n = 134, 43%) and height (n = 93, 30%), handled by multiple imputation. The cohort was heterogeneous, making model creation difficult but pragmatic; only radiotherapy-treated patients were included, and future studies could include surgically treated patients. A single pre-treatment scan was used rather than serial scans.
  • Stated: there is limited consensus on the cut-off value for sarcopenia; this study used the Prado et al. cut-off.
  • Evident: the study is a single-centre observational cohort, made no distinction by radiotherapy scheme/modality or concurrent systemic therapy, and neuromuscular impairment was present in 9% of patients, which could confound the muscle density–survival association, although multivariable analysis showed the association to be independent of neuromuscular impairment.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/0284186x.2019.1693059

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Image 1
CC-BY-NC-ND · From the PDF
Image 2
CC-BY-NC-ND · From the PDF
Image 3
CC-BY-NC-ND · From the PDF
Figure 1 Example of a CT-analysis. (a) base CT-scan (b) total muscle area measurement (c) subcutaneous fat area measurement (d) visceral fat area measurement.
Figure 1 Example of a CT-analysis. (a) base CT-scan (b) total muscle area measurement (c) subcutaneous fat area measurement (d) visceral fat area measurement.CC-BY-NC-ND · From the PDF
Figure 2 Example of muscle density. (a) patient with low muscle density. (b) patient with high muscle density.
Figure 2 Example of muscle density. (a) patient with low muscle density. (b) patient with high muscle density.CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

0 Valid · 0 Not valid · 14 Not checked · 21 Own results and interpretations

3 more claims

Create a free account to see all 35 claims and to verify the 25 references still open.

See all claims — free account
  • It may state two separate claims as one. 13
  • Probably not a substantial claim. 15

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 5

Citations

Cites

Show all 38 references

Research works printed but not linked: 1

  1. IBM Corp, IBM SPSS Statistics for Windows, Version 22.0

Cited by

See all 17

Metadata

Authors
Pielkenrood, B. J., van Urk, P. R., van der Velden, J. M., Kasperts, N., Verhoeff, J. J. C., Bol, G. H., Verkooijen, H. M., & Verlaan, J. J.
Affiliations
  • University Medical Center Utrecht (NL)
  • Utrecht University (NL)
Corresponding author
Pielkenrood, B. J.
Venue
Acta Oncologica
Published
2019-11-23
Volume
59
Issue
3
Pages
291-297
ISSN
  • 0284-186X (ISSN-L)
  • 1651-226X
OpenAlex
W2991366971
Cited by
17
References
37
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 8 · 2021: 2 · 2020: 1
FWCI
2.39
Type
journal article
Language
en
Open access
Locations
  • Acta Oncologica (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Surgery › Management of metastatic bone disease
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Medicine › Oncology › Brain Metastases and Treatment
Keywords
spinal metastases, radiotherapy, overall survival, sarcopenia, body fat distribution, visceral fat, subcutaneous adipose tissue, skeletal muscle density, Karnofsky performance status, prognostic factors, thoracic and lumbar spine
MeSH terms
Aged, Female, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Radiotherapy, Spinal Neoplasms, Survival Rate, Karnofsky Performance Status, Body Fat Distribution, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of body fat distribution and sarcopenia on the overall survival in patients with spinal metastases receiving radiotherapy treatment: a prospective cohort study. https://app.cochat.ai/papers/10.1080/0284186x.2019.1693059
The paper
Pielkenrood, B. J., van Urk, P. R., van der Velden, J. M., Kasperts, N., Verhoeff, J. J. C., Bol, G. H., Verkooijen, H. M., & Verlaan, J. J. (2020). Impact of body fat distribution and sarcopenia on the overall survival in patients with spinal metastases receiving radiotherapy treatment: a prospective cohort study. Acta Oncologica. https://doi.org/10.1080/0284186x.2019.1693059

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.